WordNet

a cellular structure that is postulated to exist in order to mediate between a chemical agent that acts on nervous tissue and the physiological response

PrepTutorEJDIC

=sense organ / 受信装置

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/07/21 22:51:09」(JST)

wiki en

An octreotide scan or octreoscan is a type of scintigraphy used to find carcinoid, pancreatic neuroendocrine tumors, and to localize sarcoidosis. Octreotide, a drug similar to somatostatin, is radiolabeled with indium-111,^[1] and is injected into a vein and travels through the bloodstream. The radioactive octreotide attaches to tumor cells that have receptors for somatostatin. A radiation-measuring device detects the radioactive octreotide, and makes pictures showing where the tumor cells are in the body.

It is also called somatostatin receptor scintigraphy and SRS.

Octreotide scanning is reported to have a sensitivity between 75% and 100% for detecting pancreatic neuroendocrine tumors.^[2]

References

^ medicinenet.com > Carcinoid Syndrome (cont.) By Dennis Lee and Jay Marks. Retrieved Mars 2011
^ Kwekkeboom, DJ; Krenning, EP (April 2002). "Somatostatin receptor imaging.". Seminars in nuclear medicine 32 (2): 84–91. doi:10.1053/snuc.2002.31022. PMID 11965603.

External links

Octreotide scan entry in the public domain NCI Dictionary of Cancer Terms

This article incorporates public domain material from the U.S. National Cancer Institute document "Dictionary of Cancer Terms".

This oncology article is a stub. You can help Wikipedia by expanding it.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 転移性胃腸膵管系神経内分泌腫瘍：症状、予後、画像検査、および生化学的モニタリング metastatic gastroenteropancreatic neuroendocrine tumors presentation prognosis imaging and biochemical monitoring
2. カルチノイド症候群および腫瘍局在の診断 diagnosis of the carcinoid syndrome and tumor localization
3. 転移性の胃腸膵管系神経内分泌腫瘍：腫瘍増殖およびホルモン過剰分泌による症状を管理
するための全身治療の選択肢 metastatic gastroenteropancreatic neuroendocrine tumors systemic therapy options to control tumor growth and symptoms of hormone hypersecretion
4. 気管支カルチノイド腫瘍：治療および予後 bronchial carcinoid tumors treatment and prognosis
5. 原発不明の神経内分泌腫瘍 neuroendocrine cancer of unknown primary site

English Journal

Detection of meningioma metastasis to liver and lung using somatostatin receptor scintigraphy.

Lanfranchi M, Nikpoor N.SourceFrom the Department of Radiology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA.
Clinical nuclear medicine.Clin Nucl Med.2013 Aug;38(8):668-70. doi: 10.1097/RLU.0b013e31829962ac.
Extracranial meningioma metastasis is rare. We report a case of a 74-year-old Caucasian man with intracranial recurrence of atypical meningioma treated with a combination of surgical resection and gamma knife radiotherapy over a 4-year period. Somatostatin receptor scintigraphy using In pentreotide
PMID 23797223

68Ga-DOTANOC PET-CT Demonstrating In Vivo Somatostatin Receptor Expression in Idiopathic Gynecomastia.

Dhull VS, Sharma P, Singla S, Singhal A, Bal C, Kumar R.SourceFrom the Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India.
Clinical nuclear medicine.Clin Nucl Med.2013 Aug;38(8):e324-5. doi: 10.1097/RLU.0b013e3182639c08.
Gynecomastia is abnormal enlargement of the male breasts due to the excess growth of glandular component. A 65-year-old man with medullary carcinoma of thyroid underwent Ga-DOTANOC PET-CT for somatostatin receptor (SSTR) scintigraphy. Extensive nodal, bone, and bone marrow disease was seen. Interest
PMID 23531768

Radiolabelled somatostatin analogue treatment in gastroenteropancreatic neuroendocrine tumours: factors associated with response and suggestions for therapeutic sequence.

Campana D, Capurso G, Partelli S, Nori F, Panzuto F, Tamburrino D, Cacciari G, Delle Fave G, Falconi M, Tomassetti P.SourceDepartment of Medical and Surgical Sciences, S. Orsola-Malpighi Hospital, University of Bologna, Via Massarenti 9, 40138, Bologna, Italy, davide.campana@unibo.it.
European journal of nuclear medicine and molecular imaging.Eur J Nucl Med Mol Imaging.2013 Aug;40(8):1197-205. doi: 10.1007/s00259-013-2402-2. Epub 2013 Apr 26.
PURPOSE: Peptide receptor radionuclide therapy (PRRT) is a relatively new treatment modality for patients with unresectable or metastatic gastroenteropancreatic neuroendocrine tumours (GEP NETs). The aim of this study was to determine the time to progression of patients treated with PRRT and to iden
PMID 23619938

Japanese Journal

Peptide receptor imaging in neuroendocrine tumors : comparison between diagnostic scintigraphy and post-therapy whole-body scan

Annals of nuclear medicine 27(7), 654-660, 2013-08-01
NAID 10031194487

膵神経内分泌腫瘍の診断

膵臓 28(6), 691-698, 2013
NAID 130004496037

Somatostatin receptor sintigraphy with ^<111>In-octreotide in pulmonary carcinoid tumours correlated with pathological and ^<18>FDG PET/CT findings

Annals of nuclear medicine 26(9), 689-697, 2012-11-01
NAID 10031126420

Related Pictures

★リンクテーブル★

リンク元	「SRS」「ソマトスタチン受容体シンチグラフィ」
関連記事	「somatostatin receptor」

「SRS」

Octreotide scan
	Diagnostics
	111In-pentetreotide scintigraphy of the 41 year-old man with ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery. Radiotracer accumulation in the left thyroid in 10/2003 (arrow). The mesenterial neuroendocrine tumor became clearly visible in 4/2005 (arrow).
ICD-9-CM	92.18
OPS-301 code	3-70c

　　[★]

「ソマトスタチン受容体シンチグラフィ」

　　[★]

英: somatostatin receptor scintigraphy, SRS

「somatostatin receptor」

　　[★]

ソマトスタチン受容体、ソマトスタチンレセプター

[1] t.com > Carcinoid Syndrome (cont.) By Dennis Lee and Jay Marks. Retrieved Mars 2011

[2] Kwekkeboom, DJ; Krenning, EP (April 2002). "Somatostatin receptor imaging.". Seminars in nuclear medicine 32 (2): 84–91. doi:10.1053/snuc.2002.31022. PMID 11965603.

匿名

検索

案内

案内

somatostatin receptor scintigraphy